Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
The antiphospholipid antibody syndrome: A case report
International Medical Case Reports Journal, Volume 5, No. 1, Year 2012
Notification
URL copied to clipboard!
Description
Antiphospholipid antibody syndrome is defined by the presence of thromboembolic complications and/or pregnancy morbidity in the presence of persistently increased titers of antiphospholipid antibodies. Its clinical presentation can be diverse and any organ can be involved, with a current impact in most surgical and medical specialties. The authors present the case of a 43-year-old man who, over a 13-year period of follow-up, presented with thrombosis of the mesenteric vein, inferior vena cava, and axillary and subclavian veins in a setting where diagnostic and therapeutic options are limited and costly. Through this case report, the authors aim to describe the evolution of this complex pathology, which to date has not been described in the authors' milieu - probably because of its challenging diagnosis and the limited treatment options available. The authors conclude that clinicians need to have a high index of suspicion of APS in patients who present with a thrombotic episode - clinicians should investigate for the presence of antiphospholipid antibodies, as early diagnosis may influence the course of the disease. Furthermore, resources for the detection of antiphospholipid antibodies should be made readily available in resource-limited settings. Finally, patient education on the importance of drug compliance, periodic monitoring, and prevention of thrombosis is indispensable, especially as mortality could be associated with the effects of vascular thrombosis and/or the effects of bleeding due to anticoagulants. © 2012 Luma et al, publisher and licensee Dove Medical Press Ltd.
Authors & Co-Authors
Luma, Henry Namme
Cameroon, Douala
Douala General Hospital
Cameroon, Yaounde
Université de Yaoundé I
Doualla, Marie Solange
Cameroon, Douala
Douala General Hospital
Cameroon, Yaounde
Université de Yaoundé I
Temfack, Elvis
Cameroon, Douala
Douala General Hospital
Bagnaka, Servais Fiacre Eloumou
Cameroon, Douala
Douala General Hospital
Mankaa, Emmanuella Wankie
Cameroon
Douala General Hospital Douala
Fofung, Dobgima
Cameroon, Douala
Muna Memorial Clinic
Statistics
Citations: 6
Authors: 6
Affiliations: 4
Identifiers
Doi:
10.2147/IMCRJ.S36129
e-ISSN:
1179142X
Research Areas
Health System And Policy
Maternal And Child Health
Sexual And Reproductive Health
Study Design
Cohort Study